Biosafety data as confidential business information.
Removal of confidentiality claims on biosafety data is necessary to adhere to standard scientific procedures of quality assurance, to increase transparency, to minimize impacts of conflicts of interests, and ultimately to improve public confidence in GMOs.
Enregistré dans:
Auteur principal: | Kaare M Nielsen |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/94e9c705bfe74588872bd00c8d05debe |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Biosafety Guidelines for Handling Microorganisms in the Teaching Laboratory: Development and Rationale
par: Elizabeth A. B. Emmert
Publié: (2013) -
Dealing with data: a case study on information and data management literacy.
par: Melissa A Haendel, et autres
Publié: (2012) -
Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research.
par: Carla Nisii, et autres
Publié: (2013) -
Guidelines for Biosafety in Teaching Laboratories Version 2.0: A Revised and Updated Manual for 2019
par: Jeffrey J. Byrd, et autres
Publié: (2019) -
Synergistic stabilization of a double mutant in chymotrypsin inhibitor 2 from a library screen in E. coli
par: Louise Hamborg, et autres
Publié: (2021)